Treatment of SARS-CoV-2: How far have we reached?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment of SARS-CoV-2: How far have we reached?

Published:2020-04-30 Issue:2 Volume:14 Page:67-72
ISSN:1881-7831
Container-title:Drug Discoveries & Therapeutics
language:en
Short-container-title:DD&T

Author:

Ahsan Waquar¹,Javed Shamama²,Bratty Mohammed Al¹,Alhazmi Hassan A.¹³,Najmi Asim¹

Affiliation:

1. Department of Pharmaceutical Chemistry, College of Pharmacy, Jazan University, Jazan, Saudi Arabia.

2. Department of Pharmaceutics, College of Pharmacy, Jazan University, Jazan, Saudi Arabia.

3. Substance Abuse and Toxicology Research Centre, Jazan University, Jazan, Saudi Arabia.

Publisher

International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.jstage.jst.go.jp/article/ddt/14/2/14_2020.03008/_pdf

Reference38 articles.

1. 1. Covid-19 Coronavirus Pandemic. https://www.worldometers.info/coronavirus/ (accessed April 18, 2020).

2. 2. Lu H. Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci Trends. 2020; 14:69-71.

3. 3. Dong L, Hu S, Gao J. Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug Discov Ther. 2020; 14:58-60.

4. 4. Sallard E, Lescure FX, Yazdanpanah Y, Mentre F, Smadja NP. Type 1 interferons as a potential treatment against COVID-19. Antivir Res. 2020; 178:104791.

5. 5. Sheahan TP, Sims AC, Leist SR, et al. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nat Commun. 2020; 11:222.

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights on Various Antiviral Drugs for Treating Patients with COVID-19;Livestock Diseases and Management;2024

2. Turkish Clinicians Opinions About COVID Treatment in 2<sup>nd</sup> and 3<sup>rd</sup> Level Hospitals What Did Change from 2021 to 2022? Results of 2 Years of Follow-up;Bagcilar Medical Bulletin;2023-09-19

3. Targeting cytokine storm as the potential anti-viral therapy: Implications in regulating SARS-CoV-2 pathogenicity;Gene;2023-09

4. PDE5 inhibitors: breaking new grounds in the treatment of COVID-19;Drug Metabolism and Personalized Therapy;2023-08-24

5. PDE5 inhibitors: breaking new grounds in the treatment of COVID-19;Drug Metabolism and Personalized Therapy;2023-08-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3